Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-012107
Filing Date
2025-02-03
Accepted
2025-02-03 11:48:34
Documents
2
Period of Report
2025-01-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5410
2 EX-24.1 hrtx-ex24_1.htm EX-24.1 15306
  Complete submission text file 0000950170-25-012107.txt   22348
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Dissanaike Sharmila (Reporting) CIK: 0001885069 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 25581311